Literature DB >> 16528968

Oleandrin-mediated oxidative stress in human melanoma cells.

Robert A Newman1, Peiying Yang, Walter N Hittelman, Tao Lu, Dah Hsi Ho, Dan Ni, Diana Chan, Mary Vijjeswarapu, Carrie Cartwright, Susan Dixon, Edward Felix, Crandell Addington.   

Abstract

While certain cardiac glycoside compounds such as oleandrin, bufalin and digitoxin are known to be associated with potent cytotoxicity to human tumor cells, the mechanisms by which this effect is produced are not clear. We now demonstrate that incubation of human malignant melanoma BRO cells with oleandrin results in a time-dependent formation of reactive oxygen species (ROS). Use of Mito-SOX and dihydroethidine dyes revealed the presence of oleandrin-mediated superoxide anions. Formation of superoxide anions correlated with a loss in cellular viability, proliferation and cellular defense mechanisms such as GSH content. Oleandrin also resulted in an unusual time-dependent mitochondrial condensation in BRO cells that could be blocked with use of N-acetyl cysteine (NAC). NAC was also shown to block ROS formation and partially prevent oleandrin-mediated loss of cellular GSH. Taken as a whole, the data suggest that exposure of human tumor cells such as BRO to oleandrin results in the formation of superoxide anion radicals that mediate mitochondrial injury and loss of cellular GSH pools. These mechanisms play a role in cardiac glycoside mediated tumor cell injury. Conversely, incubation of NAC, a precursor to GSH, largely prevents oleandrin-mediated inhibition of proliferation and mitochondria structural changes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16528968

Source DB:  PubMed          Journal:  J Exp Ther Oncol        ISSN: 1359-4117


  27 in total

1.  Short-term exposure to oleandrin enhances responses to IL-8 by increasing cell surface IL-8 receptors.

Authors:  Nune Raviprakash; Sunil Kumar Manna
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

Review 2.  The sodium pump and cardiotonic steroids-induced signal transduction protein kinases and calcium-signaling microdomain in regulation of transporter trafficking.

Authors:  Jiang Liu; Zi-Jian Xie
Journal:  Biochim Biophys Acta       Date:  2010-02-06

3.  Monosaccharide digitoxin derivative sensitize human non-small cell lung cancer cells to anoikis through Mcl-1 proteasomal degradation.

Authors:  Varisa Pongrakhananon; Todd A Stueckle; Hua-Yu Leo Wang; George A O'Doherty; Cerasela Zoica Dinu; Pithi Chanvorachote; Yon Rojanasakul
Journal:  Biochem Pharmacol       Date:  2013-11-11       Impact factor: 5.858

4.  Changes in sodium pump expression dictate the effects of ouabain on cell growth.

Authors:  Jiang Tian; Xin Li; Man Liang; Lijun Liu; Joe X Xie; Qiqi Ye; Peter Kometiani; Manoranjani Tillekeratne; Runming Jin; Zijian Xie
Journal:  J Biol Chem       Date:  2009-03-27       Impact factor: 5.157

5.  Ouabain elicits human glioblastoma cells apoptosis by generating reactive oxygen species in ERK-p66SHC-dependent pathway.

Authors:  Xiaofei Yan; FenLi Liang; Dongmin Li; Jin Zheng
Journal:  Mol Cell Biochem       Date:  2014-09-13       Impact factor: 3.396

6.  Cell type-dependent ROS and mitophagy response leads to apoptosis or necroptosis in neuroblastoma.

Authors:  F Radogna; C Cerella; A Gaigneaux; C Christov; M Dicato; M Diederich
Journal:  Oncogene       Date:  2015-12-07       Impact factor: 9.867

7.  Ex vivo activity of cardiac glycosides in acute leukaemia.

Authors:  Helene Hallböök; Jenny Felth; Anna Eriksson; Mårten Fryknäs; Lars Bohlin; Rolf Larsson; Joachim Gullbo
Journal:  PLoS One       Date:  2011-01-05       Impact factor: 3.240

8.  "The Lower Threshold" phenomenon in tumor cells toward endogenous digitalis-like compounds: Responsible for tumorigenesis?

Authors:  Heidrun Weidemann
Journal:  J Carcinog       Date:  2012-02-17

9.  The mechanisms of chansu in inducing efficient apoptosis in colon cancer cells.

Authors:  Chun Li; Saeed M Hashimi; Siyu Cao; Albert S Mellick; Wei Duan; David Good; Ming Q Wei
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-30       Impact factor: 2.629

10.  Digitoxin and its analogs as novel cancer therapeutics.

Authors:  Hosam A Elbaz; Todd A Stueckle; William Tse; Yon Rojanasakul; Cerasela Zoica Dinu
Journal:  Exp Hematol Oncol       Date:  2012-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.